Fundraising FoxBiotech Startups
11,051 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
0 investors
Intralytix develops bacteriophage-based products for food safety, sanitation, consumer products, and human therapeutics targeting antibiotic-resistant pathogens. Its work spans FDA-cleared food safety products and clinical-stage therapeutics developed with academic partners.
0 investors
0 investors
Intuitive Bio develops Colony Surveillance Assays (CSA), diagnostic kits for screening laboratory animal colonies for exposure to specific pathogens. The kits are designed for research institutions and breeding facilities requiring pathogen-free colony verification.
0 investors
IntuitiveX is a medical innovation and venture group focused on healthcare and medical technology, bringing together clinicians, scientific advisors, and IP and business specialists to develop and commercialize products. Its team spans orthopedic, spine, cardiology, and neurosurgery expertise alongside intellectual property strategy and investment support.
0 investors
0 investors
Inventprise is a clinical-stage vaccine developer using its proprietary Hydrazide-PEG-Hydrazide (Hz-PEG-Hz) linker conjugation platform to create conjugate vaccines, including a lead pediatric pneumococcal conjugate vaccine (IVT PCV-25) and candidates for Group B Streptococcus and mRNA-based vaccines. The company also operates automated manufacturing facilities intended to supply global vaccine demand.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Io Therapeutics develops small molecule retinoid drugs, including IRX4204 and IRX5183, as potential treatments for oncology, neurologic, autoimmune, and dermatologic conditions such as psoriasis. It is a biopharmaceutical company focused on clinical-stage therapeutic product development.
0 investors
0 investors
IonDX develops analytical instrumentation for biomacromolecules and nanomaterials analysis, drawing on decades of expertise in mass spectrometry and X-ray crystallography methods. The company serves life sciences researchers and biotech organizations requiring advanced analytical tools.
0 investors
iOncologi develops immunotherapy platforms designed to treat cancer by priming the immune system to attack tumors and overcoming immune resistance. The company's proprietary technologies target solid tumors and refractory cancers through personalized immune conditioning and cell-based approaches.
0 investors
0 investors
0 investors
Decode operates a platform that unifies multiomic, clinical, and real-world data with automated analytics and expert configuration to deliver validated R&D findings for precision medicine. It serves pharma, diagnostics, and health tech teams across disease areas such as autoimmune disease, oncology, and sepsis, producing results structured for commercialization, regulatory review, or program advancement.
0 investors
0 investors